Search research articles
Contact Us
Filters
Showing results (71-80 of 184) with videos related to
Page
of 19
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 1, 2014
Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS
Adriana Weinberg, Ronald Bosch, Kara Bennett, et al.
AIDS Research and Human Retroviruses
|
May 15, 2018
No Time to Delay! Fiebig Stages and Referral in Acute HIV infection: Seattle Primary Infection Program Experience
Joanne D Stekler, Kenneth Tapia, Janine Maenza, et al.
AIDS Research and Therapy
|
January 5, 2023
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance
Robert A Salata, Beatriz Grinsztejn, Justin Ritz, et al.
The Lancet. HIV
|
June 1, 2016
Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study
Alberto M La Rosa, Linda J Harrison, Babafemi Taiwo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
September 20, 2011
Clinical variables identify seronegative HCV co-infection in HIV-infected individuals
Ajay R Bharti, Scott L Letendre, Tanya Wolfson, et al.
The Journal of Infectious Diseases
|
July 28, 2011
Identifying the early post-HIV antibody seroconversion period
Frederick M Hecht, Robert Wellman, Michael P Busch, et al.
The Journal of Infectious Diseases
|
April 5, 2022
Reply to Bottanelli et al
Joshua C Cyktor, Ronald J Bosch, Hanna Mar, et al.
The Journal of Infectious Diseases
|
July 1, 2020
Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral Therapy
Joshua C Cyktor, Ronald J Bosch, Hanna Mar, et al.
AIDS (London, England)
|
January 16, 2018
Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women
Thiago S Torres, Linda J Harrison, Alberto M La Rosa, et al.
AIDS (London, England)
|
October 22, 2010
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
Tae-Wook Chun, J Shawn Justement, Danielle Murray, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 184) with videos related to
Sort By:
Page
of 19
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 1, 2014
Regulatory T cells and the risk of CMV end-organ disease in patients with AIDS
Adriana Weinberg, Ronald Bosch, Kara Bennett, et al.
AIDS Research and Human Retroviruses
|
May 15, 2018
No Time to Delay! Fiebig Stages and Referral in Acute HIV infection: Seattle Primary Infection Program Experience
Joanne D Stekler, Kenneth Tapia, Janine Maenza, et al.
AIDS Research and Therapy
|
January 5, 2023
Predictors of virologic outcome among people living with HIV who continue a protease inhibitor-based antiretroviral regimen following virologic failure with no or limited resistance
Robert A Salata, Beatriz Grinsztejn, Justin Ritz, et al.
The Lancet. HIV
|
June 1, 2016
Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study
Alberto M La Rosa, Linda J Harrison, Babafemi Taiwo, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
|
September 20, 2011
Clinical variables identify seronegative HCV co-infection in HIV-infected individuals
Ajay R Bharti, Scott L Letendre, Tanya Wolfson, et al.
The Journal of Infectious Diseases
|
July 28, 2011
Identifying the early post-HIV antibody seroconversion period
Frederick M Hecht, Robert Wellman, Michael P Busch, et al.
The Journal of Infectious Diseases
|
April 5, 2022
Reply to Bottanelli et al
Joshua C Cyktor, Ronald J Bosch, Hanna Mar, et al.
The Journal of Infectious Diseases
|
July 1, 2020
Association of Male Sex and Obesity With Residual Plasma Human Immunodeficiency Virus 1 Viremia in Persons on Long-Term Antiretroviral Therapy
Joshua C Cyktor, Ronald J Bosch, Hanna Mar, et al.
AIDS (London, England)
|
January 16, 2018
Quality of life improvement in resource-limited settings after one year of second-line antiretroviral therapy use among adult men and women
Thiago S Torres, Linda J Harrison, Alberto M La Rosa, et al.
AIDS (London, England)
|
October 22, 2010
Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication
Tae-Wook Chun, J Shawn Justement, Danielle Murray, et al.
Page
of 19